Tech Company Financing Transactions
Cleave Biosciences Funding Round
On 4/9/2013, Cleave Biosciences raised $10 million in Series A funding from New Enterprise Associates.
Transaction Overview
Company Name
Announced On
4/9/2013
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
New Enterprise Associates (Robert Garland)
Proceeds Purpose
Cleave will use the funds to move its lead program into clinical trials and advance its second discovery program.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
863 Mitten Rd. 104
Burlingame, CA 94010
USA
Burlingame, CA 94010
USA
Phone
Website
Email Address
Overview
Cleave Biosciences is focused on targets in cellular protein homeostasis pathways controlled by the ubiquitin proteasome and the autophagy systems, which are utilized by cancer cells in their growth and survival.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amy Burroughs
VP - Finance
Tanya Bowman
VP - Operations
Sujatha Venugopal-Prasad
VP - Regulatory Affairs
Kerry Kelly
Browse more venture capital transactions:
Prev: 4/9/2013: Treehouse venture capital transaction
Next: 4/9/2013: Zyme Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs